الصفحة الرئيسية>>Quercetin 3-O-β-D-(6’’-p-coumaroyl)glucopyranosyl(1→2)-α-L-rhamnopyranoside

Quercetin 3-O-β-D-(6’’-p-coumaroyl)glucopyranosyl(1→2)-α-L-rhamnopyranoside (Synonyms: Quercetin-3-O-[2-O-(6-O-p-hydroxyl-E-coumaroyl)-D-glucosyl]-(1→2)-L-rhamnoside)

رقم الكتالوجGC62058

Quercetin 3-O-β؛ -D- (6&rsquo؛ &rsquo؛ -p-coumaroyl) glucopyranosyl (1→؛ 2) -α؛ -L-rhamnopyranoside (Quercetin-3-O- [2-O- (6-O- (6-O- (6-O- (6-O- hydroxyl-E-coumaroyl) -D-glucosyl] - (1→؛ 2) -L-rhamnoside) أحد مضادات الأكسدة الرئيسية لأوراق الجنكة بيلوبا.

Products are for research use only. Not for human use. We do not sell to patients.

Quercetin 3-O-β-D-(6’’-p-coumaroyl)glucopyranosyl(1→2)-α-L-rhamnopyranoside التركيب الكيميائي

Cas No.: 143061-65-8

الحجم السعر المخزون الكميّة
5 mg
484٫20
متوفر
10 mg
822٫60
متوفر

Tel:(909) 407-4943 Email: sales@glpbio.com

مراجعات العميل

بناء على آراء العملاء.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Quercetin 3-O-β-D-(6’’-p-coumaroyl)glucopyranosyl(1→2)-α-L-rhamnopyranoside (Quercetin-3-O-[2-O-(6-O-p-hydroxyl-E-coumaroyl)-D-glucosyl]-(1→2)-L-rhamnoside) is one of the major antioxidants of Ginkgo biloba leaves[1].

[1]. Ma H, et al. A powerful on line ABTS+-CE-DAD method to screen and quantify major antioxidants for quality control of Shuxuening Injection. Sci Rep. 2018 Apr 3;8(1):5441.

مراجعات

Review for Quercetin 3-O-β-D-(6’’-p-coumaroyl)glucopyranosyl(1→2)-α-L-rhamnopyranoside

Average Rating: 5 ★★★★★ (Based on Reviews and 36 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Quercetin 3-O-β-D-(6’’-p-coumaroyl)glucopyranosyl(1→2)-α-L-rhamnopyranoside

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.